发明名称 HYPOTENSIVE COMBINATION OF VALSARTAN AND CALCIUM CHANNEL BLOCKING AGENT
摘要 FIELD: medicine, endocrinology, pharmacology, pharmacy.SUBSTANCE: invention relates to a pharmaceutical combined composition used for treatment or prophylaxis of hypertension in patients suffering with diabetes mellitus. The composition comprises AT-antagonist valsartan or its pharmaceutically acceptable salt and calcium channel blocking agent or its pharmaceutically acceptable salt, and pharmaceutically acceptable carrier. The composition elicits synergistic effect and expanded spectrum effect.EFFECT: improved and valuable medicinal properties of composition.10 cl, 3 tbl
申请公布号 RU2243768(C2) 申请公布日期 2005.01.10
申请号 RU20010102585K 申请日期 1999.07.09
申请人 NOVARTIS AG (CH) 发明人 MARK DE KOSPARO (CH);RANDI LI UEBB (US)
分类号 A61K31/41;A61K31/137;A61K31/277;A61K31/4184;A61K31/44;A61K31/4422;A61K31/4439;A61K31/495;A61K31/55;A61K31/554;A61K45/06;A61P3/10;A61P9/00;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/00;A61P13/12;A61P25/06;A61P25/28;A61P27/02;A61P39/00;A61P43/00 主分类号 A61K31/41
代理机构 代理人
主权项
地址